ABPI response to Government R&D Roadmap

01 July 2020 Posted in News by Press Office

The Government has published its R&D Roadmap with plans to cement the UK as the world’s leading research and science superpower.

The ambition for Britain to be a science superpower is exactly the direction we need to take as we leave the EU and emerge from the pandemic. Richard Torbett

The Research and Development Roadmap puts pursuing ground-breaking research, attracting global talent, and cutting unnecessary red tape at the forefront of our long-term plan to ensure the UK is the best place in the world for scientists, researchers and entrepreneurs to live, work and innovate. 

In response, Richard Torbett, Chief Executive of the ABPI, said:

"The ambition for Britain to be a science superpower is exactly the direction we need to take as we leave the EU and emerge from the pandemic.

"The life sciences sector invests more than any other in UK research.  That’s why it is critical that these plans are delivered in partnership with our companies if we are to reach the ambitious target of spending 2.4 per cent of GDP on R&D."

TAGS
  • Research and Development

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

Media enquiries

+44 (0) 20 7747 7147​​